FLT3 and acute myeloid leukemia: FLT3-ITD mutations in AML are known to be frequently found in patients with normal cytogenetics and are associated with a poor prognosis, especially in patients aged <60 years, with a low incidence of relapse (relapse) and overall survival (OS) [13,25].